Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Chia-Chi Wang"'
Autor:
Yu-Yun Shao, Shen-Yung Wang, Shi-Ming Lin, Kuan-Yang Chen, Jeng-Hwei Tseng, Ming-Chih Ho, Rheun-Chuan Lee, Po-Chin Liang, Li-Ying Liao, Kai-Wen Huang, Jui-Ting Hu, Ja-Der Liang, Kwong-Ming Kee, Chih-Lin Lin, Chung-Kwe Wang, Sheng-Nan Lu, Jing-Houng Wang, Wei-Chen Lee, Chien-Hung Chen, Chun-Jen Liu, Yi-Hsiang Huang, Chia-Chi Wang, Tsang-En Wang, Po-Heng Chuang, Chia-Yen Dai, Chiun Hsu, San-Chi Chen, Chia-Hsun Hsieh
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 4, Pp 1051-1060 (2021)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan. The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan had established a management consensus guideline in 2016. The current recommend
Autor:
Jee-Fu Huang, Pei-Chien Tsai, Chen-Hua Liu, Szu Jen Wang, Cheng Yuan Peng, Chih-Wen Lin, Sheng-Shun Yang, Chih-Lin Lin, Hsing Tao Kuo, Chi Yi Chen, Wei-Lun Tsai, Mei Hsuan Lee, Chih Lang Lin, Wan-Long Chuang, Ming-Lung Yu, Chia-Chi Wang, Lein Ray Mo, Chia Sheng Huang, Chou Kwok Hsiung, Chi Chieh Yang, Chia-Yen Dai, Ching Chu Lo, Chun Chao Chang, Chun Ting Chen, Ming-Jong Bair, Yi Hsiang Huang, Jui Ting Hu, Chien Neng Kao, Pin-Nan Cheng, Guei Ying Chen, Chao-Hung Hung, Chung Feng Huang, Tsai Yuan Hsieh, Kuo Chih Tseng, Wei Wen Su, Han Chieh Lin, Chun-Yen Lin, Chien-Hung Chen, Wen-Chih Wu, Ming Lun Yeh, Jia-Horng Kao, Chi Ming Tai, Chun-Jen Liu, Tzong Hsi Lee, Pei Lun Lee, Lee Won Chong
Publikováno v:
Liver International
Background/aims Direct‐acting antivirals (DAAs) are highly effective in treating chronic hepatitis C virus (HCV)‐infected patients. The real‐world treatment outcome in Taiwanese patients on a nationwide basis is elusive. Methods The Taiwan HCV
Autor:
Ming-Lung Yu, Yao-Chun Hsu, Yasuhito Tanaka, Chen-Hua Liu, Wan-Ting Yang, Mindie H. Nguyen, Tung-Hung Su, Chia Hsin Lin, Jia-Horng Kao, Ding-Shinn Chen, Tai-Chung Tseng, Chia-Chi Wang, Hung-Chih Yang, Chun-Jen Liu, Cheng Yuan Peng, Hsueh Chou Lai, Pei-Jer Chen
Publikováno v:
Liver Cancer
Background and Aims: Mac-2 binding protein glycosylation isomer (M2BPGi) is a novel biomarker correlating with liver fibrosis stages. However, little is known about how it predicts risks of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB)
Autor:
Yu-Ming Cheng, Chia-Chi Wang
Publikováno v:
Hepatitis Monthly. 21
Background: The serum levels of M2BPGi increase with liver fibrosis progression in patients with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. However, the diagnostic performance of M2BPGi in non-alcoholic fatty liver disease
Autor:
Chi Ming Tai, Sheng Lei Yan, Chun-Jen Liu, Pei Lun Lee, Chen-Hua Liu, Jing Houng Wang, Chia-Chi Wang, Wei-Lun Tsai, Ching Chu Lo, Jia-Horng Kao, Yen-Cheng Chiu, Ming-Jong Bair, Wei-Fan Hsu, Wan-Long Chuang, Chih-Wen Lin, Ron Nan Chien, Chih Jen Chen, Hsing Tao Kuo, Chi Chieh Yang, Chia-Yen Dai, Pin-Nan Cheng, Chao-Hung Hung, Shui Yi Tung, Chi Yi Chen, Jyh Jou Chen, Gin Ho Lo, Pei Chein Tsai, Ming-Lung Yu, Kuo Chih Tseng, Chun-Yen Lin, Jin Shiung Cheng, Wei Wen Su, Han-Chieh Lin, Jee-Fu Huang, Yi Hsiang Huang, Cheng Yuan Peng, Hsueh Chou Lai, Cheng Hsin Chu
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(10)
BACKGROUND AND AIM It is currently unknown how hepatitis C virus (HCV) eradication with pegylated interferon and ribavirin (PR) therapy affects the incidence of new-onset liver cirrhosis (LC) in patients without cirrhosis and the incidence of decompe
Autor:
Cheng Yuan Peng, Hsueh Chou Lai, Christopher Wong, Huy N. Trinh, Jiayi Li, Jia-Horng Kao, Spyros I. Siakavellas, Young-Suk Lim, Mindie H. Nguyen, Jonggi Choi, George V. Papatheodoridis, Chia-Chi Wang, Tai-Chung Tseng, Jian Zhang, Clifford Wong
Publikováno v:
Hepatology International
Background and aims Fibrosis-4 (FIB-4) index is a HCC predictor in chronic hepatitis B (CHB) patients. However, little is known about whether FIB-4 helps identify non-cirrhotic CHB patients with minimal HCC risk after prolonged nucleos(t)ide analogue
Autor:
Chia-Chi Wang, Chih-Jen Chen, Hsing-Tao Kuo, Jia-Horng Kao, Chi-Chieh Yang, Chia-Yen Dai, Cheng-Hsin Chu, Chiao-Li Khale Ke, Kuo-Chih Tseng, Meng-Hsuan Hsieh, Chung-Feng Huang, Chen-Hua Liu, Ming-Lun Yeh, Chun-Jen Liu, Jyh-Jou Chen, Chi-Ming Tai, Pin-Nan Cheng, Chao-Hung Hung, Chih-Wen Lin, Cheng Yuan Peng, Wei-Lun Tsai, Hsueh Chou Lai, Rong-Nan Chien, Pei-Chien Tsai, Chi-Yi Chen, Ming-Jong Bair, Jin-Shiung Cheng, Yi Hsiang Huang, Gin-Ho Lo, Shui-Yi Tung, Jing-Houng Wang, Pei-Lun Lee, Ming-Lung Yu, Yen-Cheng Chiu, Wan-Long Chung, Han-Chieh Lin, Jee-Fu Huang, Wei Wen Su, Sheng-Lei Yan, Ching-Chu Lo, Chun-Yen Lin
Publikováno v:
Open Forum Infectious Diseases
Background Chronic hepatitis C (CHC) has been associated with major psychoses, and interferon (IFN)-based therapy may cause psychiatric sequelae. We aimed to evaluate the effects of sustained virological response (SVR) on the incidence of major psych
Autor:
Rong-Nan Chien, Ming-Lung Yu, Chia-Chi Wang, Ching Chu Lo, Sheng Lei Yan, Jin Shiung Cheng, Ming-Jong Bair, Jing Houng Wang, Jyh Jou Chen, Chi Ming Tai, Chen-Hua Liu, Yen-Cheng Chiu, Chun-Jen Liu, Pin-Nan Cheng, Chao-Hung Hung, Jia-Horng Kao, Chung Feng Huang, Wan-Long Chuang, Chih-Wen Lin, Pei-Chien Tsai, Wei-Lun Tsai, Pei Lun Lee, Hsing Tao Kuo, Ming Lun Yeh, Chih Jen Chen, Chi Chieh Yang, Chun-Yen Lin, Chia-Yen Dai, Kuo Chih Tseng, Chi Yi Chen, Wei Wen Su, Shui Yi Tung, Gin Ho Lo, Cheng Yuan Peng, Hsueh Chou Lai, Cheng Hsin Chu, Yi Hsiang Huang, Han-Chieh Lin, Jee-Fu Huang
Publikováno v:
The American journal of gastroenterology. 115(8)
Introduction Chronic hepatitis C virus (HCV) infection is associated with nonhepatocellular carcinoma malignancies. We aimed to evaluate whether achieving a sustained virological response (SVR, defined as HCV RNA seronegativity throughout posttreatme
Autor:
Pei Lun Lee, Chi Yi Chen, Chih Jen Chen, Gin Ho Lo, Chi Chieh Yang, Wei-Lun Tsai, Chih-Wen Lin, Chia-Yen Dai, Hsing Tao Kuo, Wei-Fan Hsu, Ching Chu Lo, Jing Houng Wang, Chi Ming Tai, Chun-Jen Liu, Ming-Jong Bair, Sheng Lei Yan, Shui Yi Tung, Pei-Chien Tsai, Pin-Nan Cheng, Chao-Hung Hung, Chia-Chi Wang, Chen-Hua Liu, Jin Shiung Cheng, Yi Hsiang Huang, Cheng Yuan Peng, Hsueh Chou Lai, Cheng Hsin Chu, Jyh Jou Chen, Wan-Long Chuang, Yen-Cheng Chiu, Jee-Fu Huang, Rong-Nan Chien, Jia-Horng Kao, Ming-Lung Yu, Han-Chieh Lin, Kuo Chih Tseng, Chun-Yen Lin, Wei Wen Su
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
In patients with chronic hepatitis C (CHC), the effects of baseline characteristics, virological profiles, and therapeutic outcome to pegylated interferon plus ribavirin (PR) therapy on autoimmune diseases are unknown. Taiwanese Chronic Hepatitis C C
Publikováno v:
European Journal of Gastroenterology & Hepatology. 29:946-950
Objective As the efficacy of a direct antiviral agent is reduced in cirrhotic chronic hepatitis C patients, prolonged duration of treatment or addition of ribavirin is recommended to improve the rates of sustained virological response. However, the i